Lilly to acquire cancer biotech Scorpion, which shares a co-founder with Loxo

Eli Lil­ly, the most talked-about phar­ma­ceu­ti­cal com­pa­ny in re­cent years, is buy­ing can­cer start­up Scor­pi­on Ther­a­peu­tics about half a year af­ter its

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.